GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Meribank Biotech Co Ltd (ROCO:4724) » Definitions » Selling and Marketing Expense

Meribank Biotech Co (ROCO:4724) Selling and Marketing Expense : NT$139.2 Mil (TTM As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Meribank Biotech Co Selling and Marketing Expense?

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. Meribank Biotech Co's Selling and Marketing Expense for the six months ended in Dec. 2024 was NT$78.2 Mil. Its Selling and Marketing Expense for the trailing twelve months (TTM) ended in Dec. 2024 was NT$139.2 Mil.

Meribank Biotech Co Selling and Marketing Expense Historical Data

The historical data trend for Meribank Biotech Co's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Meribank Biotech Co Selling and Marketing Expense Chart

Meribank Biotech Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Selling and Marketing Expense
Get a 7-Day Free Trial 126.36 107.51 102.20 125.77 139.19

Meribank Biotech Co Semi-Annual Data
Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Selling and Marketing Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 54.07 56.82 68.96 60.94 78.25

Meribank Biotech Co Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.

Selling and Marketing Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$139.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Meribank Biotech Co Selling and Marketing Expense Related Terms

Thank you for viewing the detailed overview of Meribank Biotech Co's Selling and Marketing Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Meribank Biotech Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Meribank Biotech Co Ltd (ROCO:4724) » Definitions » Selling and Marketing Expense
Comparable Companies
ROCO:7776 ROCO:6973 ROCO:6850 ROCO:7773 ROCO:7427 ROCO:6564 ROCO:4131 ROCO:4195 TPE:4133 ROCO:7790 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
Sector 1, Neihu Road, 1st Floor, No.68, Neihu District, Taipei, TWN, 11493
Website
http://www.meribank.com.tw
Meribank Biotech Co Ltd is engaged in Research and development and sales of new cell drugs and also Umbilical cord blood, placenta and umbilical cord mesenchymal stem cells processing, testing and cryopreservation.

Meribank Biotech Co Headlines

No Headlines